Jun Zhu

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Venous Thromboembolism

Atrial Fibrillation

Top Venues

European heart journal

European heart journal. Cardiovascular pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Masatsugu Hori, Jun Zhu, Yan Liang, Deepak L Bhatt, Jacqueline Bosch, Stuart J Connolly, Keith A A Fox, Aldo Maggioni, Salim Yusuf, John William Eikelboom
Rivaroxaban and aspirin vs. aspirin alone in Asian compared with non-Asian patients with chronic coronary artery disease or peripheral arterial disease: the COMPASS trial. European heart journal 43 (37) (2022)
John William Eikelboom, Jacqueline Bosch, Stuart J Connolly, Jessica Tyrwitt, Keith A A Fox, Eva Muehlhofer, Christoph Neumann, Christoph Tasto, Shrikant I Bangdiwala, Rafael Diaz, Marco Alings, Gilles R Dagenais, Darryl P Leong, Eva M Lonn, Alvaro Avezum, Leopoldo Soares Piegas, Petr Widimsky, Alexander N Parkhomenko, Deepak L Bhatt, Kelley R H Branch, Jeffrey L Probstfield, Patricio Lopez-Jaramillo, Lars Rydén, Nana Pogosova, Katalin Keltai, Matyas Keltai, Georg Ertl, Stefan Stoerk, Antonio L Dans, Fernando Tomás Lanas Zanetti, Yan Liang, Jun Zhu, Christian Torp-Pedersen, Aldo Pietro Maggioni, Patrick J Commerford, Tomasz J Guzik, Thomas Vanassche, Peter Verhamme, Martin O'Donnell, Andrew M Tonkin, John D Varigos, Dragos Vinereanu, Camillo Felix, Jae-Hyung Kim, Khairul S Ibrahim, Basil S Lewis, Kaj P Metsarinne, Victor Aboyans, Phillippe Gabriel Steg, Masatsugu Hori, Ajay Kakkar, Sonia S Anand, Andre Lamy, Mukul Sharma, Salim Yusuf
Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial. European heart journal. Cardiovascular pharmacotherapy 8 (8) (2022)
Máté Vámos, Jonas Oldgren, Gi-Byoung Nam, Gregory Y H Lip, Hugh Calkins, Jun Zhu, Kwo-Chang Ueng, Ulf Ludwigs, Mattias Wieloch, John Stewart, Stefan H Hohnloser
Dronedarone vs. placebo in patients with atrial fibrillation or atrial flutter across a range of renal function: a post hoc analysis of the ATHENA trial. European heart journal. Cardiovascular pharmacotherapy 8 (4) (2022)
Jacqueline Bosch, Eva M Lonn, Hyejung Jung, Jun Zhu, Lisheng Liu, Patricio López-Jaramillo, Prem Pais, Denis Xavier, Rafael Diaz, Gilles Dagenais, Antonio Dans, Álvaro Avezum, Leopoldo Soares Piegas, Alexander Parkhomenko, Katalin Keltai, Matyas Keltai, Karen Sliwa, Claes Held, Ronald J G Peters, Basil S Lewis, Petr Jansky, Khalid Yusoff, Kamlesh Khunti F MedSci, William D Toff, Christopher M Reid, John D Varigos, Philip Joseph, Lawrence Alan Leiter, Salim Yusuf
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants. European heart journal 42 (31) (2021)